After years of developing therapeutics for ocular diseases, Paris-based genomics-focused biotech startup SparingVision is gearing up to start dosing humans.
The 6-year-old company announced a...
Redesign Health, the upstart behind a slew of telehealth apps, health care fintech companies, and comprehensive care platforms, announced on Tuesday it raised $65...
In late August, centuries-old pharmaceutical company Pfizer did something new: embraced the blockchain.
In a request to join VitaDAO, a blockchain-based biotech collective that requires...
This is a monthly feature that runs down the most active investors in U.S.-based companies, looks at some of their most interesting investments, and...
Bees have managed to survive some 100 million years without the help of venture capitalists.
In recent years, however, with many populations of crucial species...
As innovations in cell therapy continue to grow, San Francisco-based ArsenalBio this week announced it raised a whopping $220 million in Series B funding,...
Doctors need other doctors. And talking through patient bottlenecks over a game of squash (or whatever doctors do) just doesn’t cut it anymore. Enter...
